Insider Transactions in Q4 2023 at Regeneron Pharmaceuticals, Inc. (REGN)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 07
2023
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.07%
|
$82,800
$828.9 P/Share
|
|
Nov 01
2023
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,000
-4.81%
|
$783,000
$783.91 P/Share
|
|
Nov 01
2023
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+4.59%
|
$381,000
$381.4 P/Share
|
|
Oct 13
2023
|
Huda Y Zoghbi Director |
SELL
Open market or private sale
|
Direct |
1,000
-44.5%
|
$850,000
$850.0 P/Share
|
|
Oct 13
2023
|
Huda Y Zoghbi Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+30.8%
|
$391,000
$391.92 P/Share
|
|
Oct 02
2023
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,038
-4.98%
|
$858,426
$827.0 P/Share
|
|
Oct 02
2023
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,038
+4.74%
|
$386,136
$372.46 P/Share
|